Copyright
©The Author(s) 2024.
World J Diabetes. Mar 15, 2024; 15(3): 502-518
Published online Mar 15, 2024. doi: 10.4239/wjd.v15.i3.502
Published online Mar 15, 2024. doi: 10.4239/wjd.v15.i3.502
Figure 5 Jianpi Gushen Huayu Decoction moderated the toll-like receptor 4/nuclear factor-kappa B/NOD-like receptor family pyrin domain containing 3 pathway and ameliorated inflammatory injuries to kidneys.
A: Western blotting results; B: Toll-like receptor 4 levels; C: p-P65/P65 levels; D: NOD-like receptor family pyrin domain containing 3 (NLRP3) levels; E: Apoptosis-associated speck-like protein containing a CARD (ASC) levels; F: Cleaved caspase-1/caspase-1 levels; G: Mature interleukin (IL)-1β/IL-1β levels; H: IL-18 levels; I: Nlrp3 levels; J: Asc levels; K: Casp1 levels; L: Il1b levels; M: Il18 levels. aP < 0.05 as compared to the control group; bP < 0.01 as compared to the control group; cP < 0.05 as compared to the model group; dP < 0.01 as compared to the model group. JPGSH: High-dose Jianpi Gushen Huayu Decoction; TLR4: toll-like receptor 4; NLRP3: NOD-like receptor family pyrin domain containing 3; ASC: Protein apoptosis-associated speck-like protein containing a CARD; IL: Interleukin.
- Citation: Ma ZA, Wang LX, Zhang H, Li HZ, Dong L, Wang QH, Wang YS, Pan BC, Zhang SF, Cui HT, Lv SQ. Jianpi Gushen Huayu decoction ameliorated diabetic nephropathy through modulating metabolites in kidney, and inhibiting TLR4/NF-κB/NLRP3 and JNK/P38 pathways. World J Diabetes 2024; 15(3): 502-518
- URL: https://www.wjgnet.com/1948-9358/full/v15/i3/502.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i3.502